The Riyadh Global Medical Biotechnology Summit brings together thought leaders to explore the ways in which medical biotech collaborations around the world can push the boundaries of our existing ...

The Riyadh Global Medical Biotechnology Summit (RGMBS) 2021 sought to present the latest developments in medical biotechnology, together with potential opportunities for collaboration, to local ...

"Biotechnology saves lives despite ethical controversy: author Albert Sasson (new book)" For many people, biotechnology means genetically modified organisms, alien species, toxic weapons, or ...

Nature Biotechnology is a peer reviewed scientific journal published monthly by the Nature Publishing Group. The chief editor is Andrew Marshall who is part of an in-house team of editors. The focus ...

Trends in Biotechnology is unique in drawing together a wide readership of scientists and engineers from the many disciplines of the applied biosciences. As in the successful biotechnology companies ...

Biotechnology is a rapidly growing field that combines biology and technology to develop innovative products and solutions in various sectors, including healthcare, agriculture, and environmental ...

Biotechnology research and development is a dynamic field that harnesses living organisms, cells, and biological processes to create innovative products or improve existing ones. By combining biology ...

A WOMAN has been told she is at high risk of developing breast cancer, and her doctor has asked her to come in for tests. At the surgery, she is handed a mouthwash and told to gargle. In minutes, she ...

RAS AL KHAIMAH, UAE: With the global biotechnology industry expected to reach $465.9 billion in 2024 and growing at a compound annual growth rate (CAGR) of 12.3%, demand for biotechnology graduates is ...

Interview with the Chairman and CEO: MAIA Biotechnology Inc. (NYSEAMERICAN:MAIA) Vlad Vitoc Interview with the Chairman and CEO: Mira Pharmaceuticals, Inc. (NASDAQ:MIRA) and Telomir Pharmaceuticals, ...

Most technological innovations are driven by the commercial sector, rather than the Defense Department. This is particularly true of emerging biotechnology. Recognizing this, the Pentagon has invested ...